EXO1 and neoplasm: Analysis of data from TCGA database through the UALCAN webpage revealed that the promoter methylation level of EXO1 was significantly lower in tumor tissues compared to normal tissues in various cancers, including BRCA, UCEC, and THCA (Figure 6A).